For: | Choi AH, Kim J, Chao J. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond. World J Gastroenterol 2015; 21(24): 7343-7348 [PMID: 26139980 DOI: 10.3748/wjg.v21.i24.7343] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i24/7343.htm |
Number | Citing Articles |
1 |
Natalie Liu, Yiwei Xu, Amir A. Rahnemai-Azar, Daniel E. Abbott, Sharon M. Weber, Anne O. Lidor. National Underutilization of Neoadjuvant Chemotherapy for Gastric Cancer. Journal of Gastrointestinal Surgery 2020; 24(4): 949 doi: 10.1007/s11605-019-04439-y
|
2 |
Christina Hadzitheodorou, Rebecca A. Moss, Timothy J. Kennedy, Salma K. Jabbour. Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series. Case Reports in Oncology 2017; 10(1): 308 doi: 10.1159/000464280
|
3 |
Xiaolong Tang, Qingsi He, Hui Qu, Guorui Sun, Jia Liu, Lei Gao, Jingbo Shi, Jianhong Ye, Yahang Liang. Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6012-7
|
4 |
Balkarn S. Thind, Thomas D. Mullen, Erin Healy, Nicholas Serrano, Diana M. Christensen, Trevor T. Miller, Jing Zeng, Brant K. Oelschlager, Shilpen A. Patel. Trimodality therapy for resectable gastric cancer: analysis of the benefit in radiation. International Journal of Surgery Oncology 2017; 2(1): e06 doi: 10.1097/IJ9.0000000000000006
|
5 |
Guilherme Luiz Stelko Pereira, Eduardo Saadi Neto. Diffuse Gastric Cancer. 2018; : 65 doi: 10.1007/978-3-319-95234-5_8
|
6 |
Caijin Zhou, Linxia Chen, Rihong Chen, Feipeng Xu, Zhe Huang, Renwei Huang, Weiwei Wang, Qingwen Xu. miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway. Journal of Chemotherapy 2022; 34(1): 35 doi: 10.1080/1120009X.2021.1936957
|
7 |
Xiaoyuan Dong, Guorui Sun, Hui Qu, Qingsi He, Zhaofan Hao. Prognostic Significance of Signet-Ring Cell Components in Patients With Gastric Carcinoma of Different Stages. Frontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.642468
|
8 |
Maddalena Leongito, Raffaele Palaia, Rossana Casaretti, Fabiana Tatangelo, Francesca Foschini, Annabella Di Mauro, Andrea Belli, Vittorio Albino. Role of shrinkage in esophageal–gastric junction cancer. Clinical Case Reports 2023; 11(6) doi: 10.1002/ccr3.6982
|
9 |
Silvia Guerrero-Macías, Raúl Pinilla-Morales, Helena Facundo-Navia, María Eugenia Manrique-Acevedo, Juliana Rendón-Hernández, Mario Rey-Ferro, Mario Abadía-Díaz, ´Óscar Guevara-Cruz, Jorge Vélez-Bernal, Ricardo Oliveros-Wilches. Situación actual de la laparoscopía de estadificación en pacientes con cáncer gástrico en Colombia: ¿Cómo lo estamos haciendo?. Revista Colombiana de Cirugía 2023; 38(1): 74 doi: 10.30944/20117582.2182
|
10 |
Mohamed J. Saadh, Morug Salih Mahdi, Omer Qutaiba B. Allela, Tuqa S. Alazzawi, Mohammed ubaid, Nodir M. Rakhimov, Zainab H. Athab, Pushpamala Ramaiah, Lathamangeswari Chinnasamy, Fahad Alsaikhan, Bagher Farhood. Critical role of miR-21/exosomal miR-21 in autophagy pathway. Pathology - Research and Practice 2024; 257: 155275 doi: 10.1016/j.prp.2024.155275
|
11 |
Seong-A Jeong, Sehee Kim, In-Seob Lee, Moon-Won Yoo, Beom Su Kim. Does total omentectomy prevent peritoneal seeding for advanced gastric cancer with serosal invasion?. Surgical Endoscopy 2024; 38(1): 97 doi: 10.1007/s00464-023-10514-y
|
12 |
Lei Gao, Juan Xue, Xiaomin Liu, Lei Cao, Ruifang Wang, Liangliang Lei. A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients. Aging 2021; 13(23): 25453 doi: 10.18632/aging.203765
|
13 |
D. Schizas, K. S. Mylonas, K. P. Economopoulos, S. Tasigiorgos, D. Patouras, I. Karavokyros, T. Liakakos. Laparoscopic surgery for gastric cancer: a systematic review. European Surgery 2015; 47(6): 286 doi: 10.1007/s10353-015-0350-8
|
14 |
Xiao-Cui Hong, Qi-Lian Liang, Xing-Bo Luo, Ke-Hui Hu, Hai-Xia Yang, Wen-ting Ou, Hui-Jie Zhang. Clinical study of XiangShaLiuJunZi decoction combined with S-1 as maintenance therapy for stage III or IV gastric carcinoma and colorectal carcinoma. Medicine 2020; 99(19): e20081 doi: 10.1097/MD.0000000000020081
|
15 |
Jaeseung Shin, Joon Seok Lim, Yong-Min Huh, Jie-Hyun Kim, Woo Jin Hyung, Jae-Joon Chung, Kyunghwa Han, Sungwon Kim. A radiomics-based model for predicting prognosis of locally advanced gastric cancer in the preoperative setting. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81408-z
|
16 |
Jarlath C. Bolger, Mohammed Al Azzawi, Jack Whooley, Eamonn M. Bolger, Luke Trench, Jack Allen, Michael E. Kelly, Conor Brosnan, Mayilone Arumugasamy, William B. Robb. Surgery by a minimally invasive approach is associated with improved textbook outcomes in oesophageal and gastric cancer. European Journal of Surgical Oncology 2021; 47(9): 2332 doi: 10.1016/j.ejso.2021.03.240
|
17 |
Sang-Ho Jeong, Kyung Won Seo, Jae-Seok Min. Intraoperative Tumor Localization of Early Gastric Cancers. Journal of Gastric Cancer 2021; 21(1): 4 doi: 10.5230/jgc.2021.21.e4
|
18 |
Yifan Gu, Zhewei Fei, Ronghua Zhu. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Anti-Cancer Drugs 2020; 31(4): 385 doi: 10.1097/CAD.0000000000000886
|
19 |
PrameelaG Chelakkot, Rahul Ravind, K Sruthi, Durgapoorna Menon. Treatment in resectable non-metastatic adenocarcinoma of stomach: Changing paradigms. Indian Journal of Cancer 2019; 56(1): 74 doi: 10.4103/ijc.IJC_375_18
|
20 |
Hongyan Yin, Qian Yao, Yi Xie, Dongfeng Niu, Wenya Jiang, Huiying Cao, Xujiao Feng, Yanyan Li, Yilin Li, Xiaotian Zhang, Lin Shen, Yang Chen. Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma. Cancer Medicine 2023; 12(19): 19633 doi: 10.1002/cam4.6597
|
21 |
Marianna V. Papageorge, Susanna W.L. de Geus, Jian Zheng, Alison P. Woods, Sing Chau Ng, Michael R. Cassidy, David McAneny, Jennifer F. Tseng, Teviah E. Sachs. The Discordance of Clinical and Pathologic Staging in Locally Advanced Gastric Adenocarcinoma. Journal of Gastrointestinal Surgery 2021; 25(6): 1363 doi: 10.1007/s11605-021-04993-4
|
22 |
Jun Ren, Zhiqing Hu, Gengming Niu, Jie Xia, Xing Wang, Runqi Hong, Jiawei Gu, Daorong Wang, Chongwei Ke. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR. The FASEB Journal 2023; 37(3) doi: 10.1096/fj.202200400RR
|
23 |
Alexander W. Phillips, Sjoerd M. Lagarde, Maziar Navidi, Babbet Disep, S. Michael Griffin. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy. Annals of Surgery 2017; 265(4): 750 doi: 10.1097/SLA.0000000000001737
|
24 |
T. Douchy, L. Lemoine, K. Van der Speeten. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; : 103 doi: 10.1007/978-981-10-7053-2_5
|
25 |
Gaurav Das, Karma Doma Bhutia, Joydeep Purkayastha, Abhijit Talukdar. Early-Onset Gastric Cancer from a Geographic Area of High Gastric Cancer Incidence in North-East India: a Retrospective Study. Indian Journal of Surgical Oncology 2023; 14(2): 308 doi: 10.1007/s13193-022-01675-8
|
26 |
I. D. Amelina, A. M. Karachun, D. V. Nesterov, L. N. Shevkunov, A. S. Artemieva, S. S. Bagnenko, S. L. Trofimov. ROLE OF COMPUTED TOMOGRAPHY WITH PNEUMOGASTROGRAPHY IN DETERMINING THE REGRESSION GRADE OF LOCALLY ADVANCED GASTRIC CANCER AFTER NEOADJUVANT CHEMOTHERAPY. Siberian journal of oncology 2021; 20(5): 18 doi: 10.21294/1814-4861-2021-20-5-18-30
|
27 |
Umme Hani, Riyaz Ali M. Osmani, Sabina Yasmin, B. H. Jaswanth Gowda, Hissana Ather, Mohammad Yousuf Ansari, Ayesha Siddiqua, Mohammed Ghazwani, Adel Al Fatease, Ali H. Alamri, Mohamed Rahamathulla, M. Yasmin Begum, Shadma Wahab. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy. Pharmaceutics 2022; 14(8): 1576 doi: 10.3390/pharmaceutics14081576
|
28 |
Lin Yang, Ya-Nan Liu, Yi Gu, Qi Guo. Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin <i>via</i> inhibiting PI3K/AKT/mTOR and MAPK signaling. World Journal of Gastrointestinal Oncology 2023; 15(10): 1739-1755 doi: 10.4251/wjgo.v15.i10.1739
Abstract(442) |
Core Tip(467) |
Full Article(HTML)(1589)
|
Full Article with Cover (PDF)-11656K(95)
|
Full Article (Word)-3367K(24)
|
Audio-403K(5)
|
Peer-Review Report-200K(59)
|
Answering Reviewers-94K(60)
|
Full Article (PDF)-11456K(108)
|
Full Article (XML)-104K(55)
|
Times Cited (5)
|
Total Visits (4694)
|
Open
|
29 |
Youjin Kim, Kyoung-Mee Kim, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park. Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial. Journal of Gastric Cancer 2018; 18(4): 348 doi: 10.5230/jgc.2018.18.e34
|
30 |
Daniela Lazar, Sorina Taban, Marioara Cornianu, Alexandra Faur, Ioan Romosan, Adrian Goldis. Gastric Cancer. 2017; doi: 10.5772/intechopen.69737
|
31 |
Qing Zhong, Qi-Yue Chen, Amilcare Parisi, Yu-Bin Ma, Guang-Tan Lin, Jacopo Desiderio, Su Yan, Jian-Wei Xie, Jia-Bin Wang, Jun-Fang Hou, Jian-Xian Lin, Jun Lu, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ze-Ning Huang, Ju-Li Lin, Zhi-Yu Liu, Si-Jin Que, Ping Li, Chao-Hui Zheng, Chang-Ming Huang. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study. The Oncologist 2021; 26(1): e99 doi: 10.1634/theoncologist.2020-0022
|
32 |
Jun-Yan Liu, Jing Yao, Jia-Jia Liu, Tao He, Fang-Jie Wang, Tian-Yu Xie, Jian-Xin Cui, Xiao-Dong Yang. LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1020255
|
33 |
Qingqiang Dai, Tianqi Zhang, Chen Li. <p>LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway</p>. Cancer Management and Research 2020; : 1929 doi: 10.2147/CMAR.S243796
|
34 |
Adriana C. Gamboa, Joshua H. Winer. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer. Cancers 2019; 11(11): 1662 doi: 10.3390/cancers11111662
|
35 |
Wen Wang, Kangle Zhang, Lingling Dai, Aihua Hou, Peng Meng, Jipeng Ma. Investigating the protective effects of Astragalus polysaccharides on cyclophosphamide-induced bone marrow suppression in mice and bone mesenchymal stem cells. Molecular Immunology 2024; 171: 93 doi: 10.1016/j.molimm.2024.05.008
|
36 |
Sandro Pasquali, Guang Yim, Ravinder S. Vohra, Simone Mocellin, Donald Nyanhongo, Paul Marriott, Ju Ian Geh, Ewen A. Griffiths. Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma. Annals of Surgery 2017; 265(3): 481 doi: 10.1097/SLA.0000000000001905
|
37 |
Wenzhong Zhu, Lulu Tan, Tiantian Ma, Zhijie Yin, Jinbo Gao. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression. Digestive and Liver Disease 2022; 54(11): 1573 doi: 10.1016/j.dld.2022.02.011
|
38 |
Qi Wang, Wen‐cheng Zhang, Bao‐zhong Zhang, Hua‐lei Zhang, Jia‐qi Zhang, Qing‐song Pang, Ping Wang. Application of the proposed eighth edition of the American Joint Committee on Cancer/Union of International Cancer Control esophageal cancer staging system in esophageal cancer patients. Precision Radiation Oncology 2019; 3(2): 52 doi: 10.1002/pro6.65
|
39 |
Jiasheng Xu, Xinlu Wang, Qiwen Ke, Kaili Liao, Yanhua Wan, Kaihua Zhang, Guanyu Zhang, Xiaozhong Wang. Combined bioinformatics technology to explore pivot genes and related clinical prognosis in the development of gastric cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94291-5
|
40 |
Robin Gaupset, Lars Lohne Eftang, Odd Langbach, Katrin Fridrich, Arne Borthne, Jonn Terje Geitung, Sutharsan Suntharalingam, Dejan Ignjatovic, Ola Røkke. Improved Survival after Implementation of Multidisciplinary Team Meetings, Perioperative Chemotherapy, Extended Lymphnode Dissection and Laparoscopic Surgery in the Treatment of Advanced Gastric Cancer. Journal of Cancer Therapy 2018; 9(02): 106 doi: 10.4236/jct.2018.92012
|
41 |
Omar Abdel-Rahman. Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study. Journal of Comparative Effectiveness Research 2021; 10(15): 1143 doi: 10.2217/cer-2021-0113
|
42 |
Diana Galos, Loredana Balacescu, Radu Vidra, Daniel Sur. Real-World Data on Second-Line Therapy with Ramucirumab for Metastatic Gastric Cancer: A Two-Center Study on Romanian Population. Life 2023; 13(12): 2300 doi: 10.3390/life13122300
|
43 |
Lei Zheng, Jia Lu, Dalu Kong, Yang Zhan. Single-cell sequencing analysis revealed that WDR72 was a novel cancer stem cells related gene in gastric cancer. Heliyon 2024; 10(15): e35549 doi: 10.1016/j.heliyon.2024.e35549
|
44 |
Benjamin W. Fisher, Marcus Fluck, Katelyn Young, Mohsen Shabahang, Joseph Blansfield, Tania K. Arora. Urgent Surgery for Gastric Adenocarcinoma: A Study of the National Cancer Database. Journal of Surgical Research 2020; 245: 619 doi: 10.1016/j.jss.2019.07.073
|
45 |
Ivy N. Haskins, Matthew D. Kroh, Richard L. Amdur, Jeffrey L. Ponksy, John H. Rodriguez, Khashayar Vaziri. The Effect of Neoadjuvant Chemoradiation on Anastomotic Leak and Additional 30-Day Morbidity and Mortality in Patients Undergoing Total Gastrectomy for Gastric Cancer. Journal of Gastrointestinal Surgery 2017; 21(10): 1577 doi: 10.1007/s11605-017-3496-9
|
46 |
Silvia Ministrini, Leonardo Solaini, Chiara Cipollari, Silvia Sofia, Elisabetta Marino, Alessia D’Ignazio, Maria Bencivenga, Guido A. M. Tiberio. Surgical treatment of hepatic metastases from gastric cancer. Updates in Surgery 2018; 70(2): 273 doi: 10.1007/s13304-018-0536-2
|
47 |
Wanjing Feng, Xiaodong Zhu. Efficacy prediction of targeted therapy for gastric cancer: The current status (Review). Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9145
|
48 |
Weihong Guo, Zhian Chen, Xiaoli Feng, Guodong Shen, Huilin Huang, Yanrui Liang, Bingxia Zhao, Guoxin Li, Yanfeng Hu. Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP). Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00874-9
|
49 |
Georgios D. Lianos, Christina D. Bali, Dimitrios Schizas, Michail Mitsis, Federica Galli, Stefano Rausei. Management of positive peritoneal cytology gastric cancer patients. Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons 2022; 42(3): e06 doi: 10.1097/IA9.0000000000000005
|
50 |
Gangling Tong, Shuluan Li, Lin Lin, Lirui He, Li Wang, Guoqing Lv, Ruinian Zheng, Shubin Wang. <p>Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study</p>. Cancer Management and Research 2020; : 2481 doi: 10.2147/CMAR.S239420
|
51 |
Jin-Ming Shi, Ning Li, Li-Ming Jiang, Lin Yang, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Ning-Ning Lu, Shu-Nan Qi, Bo Chen, Ye-Xiong Li, Dong-Bing Zhao, Yuan Tang, Jing Jin. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58177-6
|
52 |
Linda Agolli, Luca Nicosia. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?. World Journal of Gastrointestinal Oncology 2018; 10(9): 271-281 doi: 10.4251/wjgo.v10.i9.271
|
53 |
Shrawan G. Gaitonde, Anton J. Bilchik. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 804 doi: 10.1016/B978-0-323-40232-3.00069-8
|
54 |
Junjie Zeng, Dan Song, Kai Li, Fengyu Cao, Yongbin Zheng. Deep learning model for predicting postoperative survival of patients with gastric cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1329983
|
55 |
F. Pardo, J. Osorio, C. Miranda, S. Castro, M. Miró, A. Luna, E. Garsot, D. Momblán, G. Galofré, J. Rodríguez-Santiago, M. Pera. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma. Clinical and Translational Oncology 2020; 22(8): 1335 doi: 10.1007/s12094-019-02261-1
|
56 |
Elisa Boldrin, Maria Assunta Piano, Rita Alfieri, Marcodomenico Mazza, Loretta Vassallo, Antonio Scapinello, Pierluigi Pilati, Matteo Curtarello. MSI Analysis in Solid and Liquid Biopsies of Gastroesophageal Adenocarcinoma Patients: A Molecular Approach. International Journal of Molecular Sciences 2021; 22(14): 7244 doi: 10.3390/ijms22147244
|
57 |
Ming Gao, Liying Liu, Yudan Yang, Mengyi Li, Qingqing Ma, Zhiwei Chang. LncRNA HCP5 Induces Gastric Cancer Cell Proliferation, Invasion, and EMT Processes Through the miR-186-5p/WNT5A Axis Under Hypoxia. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.663654
|
58 |
Johannes Asplund, Fredrik Mattsson, Magdalena Plecka-Östlund, Sheraz R. Markar, Jesper Lagergren. Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study. Acta Oncologica 2022; 61(4): 425 doi: 10.1080/0284186X.2022.2025612
|
59 |
Zhe-Han Bao, Can Hu, Yan-Qiang Zhang, Peng-Cheng Yu, Yi Wang, Zhi-Yuan Xu, Huan-Ying Fu, Xiang-Dong Cheng. Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers. World Journal of Gastrointestinal Oncology 2024; 16(4): 1281-1295 doi: 10.4251/wjgo.v16.i4.1281
Abstract(285) |
Core Tip(285) |
Full Article(HTML)(1314)
|
Full Article with Cover (PDF)-687K(127)
|
Audio-1435K(8)
|
Peer-Review Report-234K(32)
|
Answering Reviewers-88K(33)
|
Supplementary Material-198K(35)
|
Full Article (PDF)-457K(78)
|
Full Article (XML)-183K(31)
|
Times Cited (1)
|
Total Visits (3535)
|
Open
|
60 |
Ayumi Seko-Nitta, Yukihiro Nagatani, Yoko Murakami, Yoshiyuki Watanabe, Norihisa Nitta, Kiyoshi Murata, Shizuki Takemura, Satoshi Murata. 18F-fluorodeoxyglucose uptake in advanced gastric cancer correlates with histopathological subtypes and volume of tumor stroma. European Journal of Radiology 2021; 145: 110048 doi: 10.1016/j.ejrad.2021.110048
|
61 |
Xiaobo Yang, Zheng Zhu, Tianyu Liang, Xiaoju Lei. Comprehensive analysis of anoikis-related genes in prognosis and immune infiltration of gastric cancer based on bulk and single-cell RNA sequencing data. Journal of Cancer Research and Clinical Oncology 2023; 149(14): 13163 doi: 10.1007/s00432-023-05157-4
|
62 |
Yan Zhu, Yu-Li Liu, Ming-Dong Wu, Yong-Wei Zhuang, Shu-Fang Ye, Xu-Hong Shi. Downregulation of miRNA-214 inhibits cisplatin resistance, cell migration, and epithelial interstitial transformation in gastric cancer SGC-7901/DDP cells. World Chinese Journal of Digestology 2019; 27(12): 742 doi: 10.11569/wcjd.v27.i12.742
|
63 |
Rhami Khorfan, Cary Jo R. Schlick, Anthony D. Yang, David D. Odell, David J. Bentrem, Ryan P. Merkow. Utilization of Minimally Invasive Surgery and Its Association with Chemotherapy for Locally Advanced Gastric Cancer. Journal of Gastrointestinal Surgery 2020; 24(2): 243 doi: 10.1007/s11605-019-04410-x
|
64 |
Xianyu Hu, Zhenglin Wang, Qing Wang, Ke Chen, Qijun Han, Suwen Bai, Juan Du, Wei Chen. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering. Biomedicine & Pharmacotherapy 2021; 144: 112222 doi: 10.1016/j.biopha.2021.112222
|
65 |
Bing Wang, Xibo Sun, Ruiqing Ma, Zhenpeng Yang, Huazhen Tang, Shuai Lu, Jinxiu Qu, Yuying Wang, Benqiang Rao, Hongbin Xu. Prognostic value of the ascites characteristics in pseudomyxoma peritonei originating from the appendix. Frontiers in Surgery 2023; 9 doi: 10.3389/fsurg.2022.967296
|
66 |
Daniela Cornelia Lazăr, Sorina Tăban, Marioara Cornianu, Alexandra Faur, Adrian Goldiş. New advances in targeted gastric cancer treatment. World Journal of Gastroenterology 2016; 22(30): 6776-6799 doi: 10.3748/wjg.v22.i30.6776
|
67 |
Zhenyuan Qian, Wenfa Lin, Xufan Cai, Jianzhang Wu, Kun Ke, Zaiyuan Ye, Fang Wu. WYC-209 suppresses gastric cancer by down-regulating FGF18 via inactivating the STAT3 signaling pathway. European Journal of Pharmacology 2024; 983: 176957 doi: 10.1016/j.ejphar.2024.176957
|
68 |
Xin Wang, Dong-Bing Zhao, Lin Yang, Yihebali Chi, Hong Zhao, Li-Ming Jiang, Jun Jiang, Yuan Tang, Ning Li, Wen-Yang Liu, Li-Zhou Dou, Shuang-Mei Zou, Li-Yan Xue, Jian-Song Ren, Yan-Tao Tian, Xu Che, Chun-Guang Guo, Xiao-Feng Bai, Yue-Min Sun, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Ye-Xiong Li, Jing Jin. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.870741
|
69 |
Nikolaos Charalampakis, Sergios Tsakatikas, Dimitrios Schizas, Stylianos Kykalos, Maria Tolia, Rodanthi Fioretzaki, Georgios Papageorgiou, Ioannis Katsaros, Ahmed Adel Fouad Abdelhakeem, Matheus Sewastjanow-Silva, Jane E Rogers, Jaffer A Ajani. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. World Journal of Gastrointestinal Oncology 2022; 14(1): 181-202 doi: 10.4251/wjgo.v14.i1.181
|
70 |
Hannah G. McDonald, Megan M. Harper, Kristen Hill, Anqi Gao, Angelica L. Solomon, Charles J. Bailey, Miranda Lin, Mautin Barry-Hundeyin, Michael J. Cavnar, Samuel H. Mardini, Prakash J. Pandalai, Reema A. Patel, Jill M. Kolesar, Justin A. Rueckert, Lawrence Hookey, Mark Ropeleski, Shaila J. Merchant, Joseph Kim, Mei Gao. Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses. Cancers 2023; 15(11): 3036 doi: 10.3390/cancers15113036
|
71 |
Alberto Biondi, Annamaria Agnes, Federica Del Coco, Carmelo Pozzo, Antonia Strippoli, Domenico D'Ugo, Roberto Persiani. Preoperative therapy and long-term survival in gastric cancer: One size does not fit all. Surgical Oncology 2018; 27(3): 575 doi: 10.1016/j.suronc.2018.07.006
|
72 |
Michelle R. Ju, John D. Karalis, James-Michael Blackwell, John C. Mansour, Patricio M. Polanco, Mathew Augustine, Adam C. Yopp, Herbert J. Zeh, Sam C. Wang, Matthew R. Porembka. Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse Outcomes. Annals of Surgical Oncology 2021; 28(5): 2831 doi: 10.1245/s10434-020-09403-8
|